S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.81%) $83.17
Gas
(1.35%) $1.949
Gold
(-0.17%) $2 343.30
Silver
(0.16%) $27.58
Platinum
(0.78%) $929.30
USD/EUR
(-0.31%) $0.932
USD/NOK
(-0.41%) $10.98
USD/GBP
(-0.41%) $0.797
USD/RUB
(0.25%) $92.11

リアルタイムの更新: WuXi AppTec Co., Ltd. [2359.HK]

取引所: HKSE セクター: Healthcare 産業: Diagnostics & Research
最終更新日時29 4月 2024 @ 12:59

4.55% HKD 36.80

Live Chart Being Loaded With Signals

Commentary (29 4月 2024 @ 12:59):

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally...

Stats
本日の出来高 7.26M
平均出来高 10.39M
時価総額 135.91B
EPS HKD0.940 ( 2023-10-31 )
Last Dividend HKD0.989 ( 2023-06-05 )
Next Dividend HKD0 ( N/A )
P/E 10.51
ATR14 HKD0.0670 (0.18%)

ボリューム 相関

長: 0.19 (neutral)
短: 0.32 (neutral)
Signal:(51.655) Neutral

WuXi AppTec Co., Ltd. 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

WuXi AppTec Co., Ltd. 相関 - 通貨/商品

The country flag 0.24
( neutral )
The country flag 0.01
( neutral )
The country flag 0.00
( neutral )
The country flag -0.20
( neutral )
The country flag -0.11
( neutral )
The country flag -0.11
( neutral )

WuXi AppTec Co., Ltd. 財務諸表

Annual 2023
収益: HKD40.34B
総利益: HKD16.61B (41.18 %)
EPS: HKD3.27
FY 2023
収益: HKD40.34B
総利益: HKD16.61B (41.18 %)
EPS: HKD3.27
FY 2022
収益: HKD39.35B
総利益: HKD14.68B (37.30 %)
EPS: HKD3.15
FY 2021
収益: HKD22.90B
総利益: HKD8.31B (36.28 %)
EPS: HKD1.820

Financial Reports:

No articles found.

WuXi AppTec Co., Ltd. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.989
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

WuXi AppTec Co., Ltd. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.38 - Increase likely (47.63%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.281 2019-06-17
Last Dividend HKD0.989 2023-06-05
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 5 --
Total Paid Out HKD2.45 --
Avg. Dividend % Per Year 0.00% --
Score 3.55 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 7.38
Div. Directional Score 10.00 --
Next Divdend (Est)
(2025-03-31)
HKD1.307 Estimate 3.09 %
Dividend Stability
0.25 Very Poor
Dividend Score
3.55
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
2359.HK Ex Dividend Knight 2023-06-05 Annually 0 0.00%
1345.HK Ex Dividend Junior 2023-10-04 Semi-Annually 0 0.00%
0390.HK Ex Dividend Junior 2023-07-19 Annually 0 0.00%
6626.HK Ex Dividend Knight 2023-09-04 Annually 0 0.00%
1897.HK Ex Dividend Knight 2023-07-05 Semi-Annually 0 0.00%
0921.HK Ex Dividend Junior 2023-07-10 Sporadic 0 0.00%
0052.HK Ex Dividend Knight 2023-09-12 Semi-Annually 0 0.00%
2869.HK Ex Dividend Junior 2023-06-20 Annually 0 0.00%
1469.HK Ex Dividend Knight 2023-08-29 Semi-Annually 0 0.00%
0546.HK Ex Dividend Knight 2023-09-18 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2381.5005.247.86[0 - 0.5]
returnOnAssetsTTM0.1301.2005.656.78[0 - 0.3]
returnOnEquityTTM0.1871.5009.0410.00[0.1 - 1]
payoutRatioTTM0.287-1.0007.13-7.13[0 - 1]
currentRatioTTM2.060.8004.693.75[1 - 3]
quickRatioTTM1.6100.8005.244.19[0.8 - 2.5]
cashRatioTTM0.9331.5005.938.89[0.2 - 2]
debtRatioTTM0.0780-1.5008.70-10.00[0 - 0.6]
interestCoverageTTM61.331.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM4.202.008.6010.00[0 - 30]
freeCashFlowPerShareTTM2.352.008.8310.00[0 - 20]
debtEquityRatioTTM0.104-1.5009.58-10.00[0 - 2.5]
grossProfitMarginTTM0.4121.0006.476.47[0.2 - 0.8]
operatingProfitMarginTTM0.2941.0006.116.11[0.1 - 0.6]
cashFlowToDebtRatioTTM2.181.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.5480.8009.687.75[0.5 - 2]
Total Score12.79

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM10.121.0009.080[1 - 100]
returnOnEquityTTM0.1872.509.3810.00[0.1 - 1.5]
freeCashFlowPerShareTTM2.352.009.2210.00[0 - 30]
dividendYielPercentageTTM3.041.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM4.202.008.6010.00[0 - 30]
payoutRatioTTM0.2871.5007.13-7.13[0 - 1]
pegRatioTTM0.5031.5009.980[0.5 - 2]
operatingCashFlowSalesRatioTTM0.3111.0004.740[0.1 - 0.5]
Total Score7.38

WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。